Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company ExCellThera Inc.
DescriptionCombination of UM171, a small molecule and bioreactor technology that targets the expansion of long-term human stem cells
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationAcute myelogenous leukemia (AML)
Indication DetailsTreat acute myelogenous leukemia (AML)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today